These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21539486)

  • 21. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
    Gauthier S; Juby A; Morelli L; Rehel B; Schecter R;
    Curr Med Res Opin; 2006 Nov; 22(11):2251-65. PubMed ID: 17076986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
    Stoppe G; Pirk O; Haupt M
    Gesundheitswesen; 2005 Jan; 67(1):20-6. PubMed ID: 15672302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
    Molinuevo JL; Berthier ML; Rami L
    Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease.
    Wesnes K; Edgar C; Andreasen N; Annas P; Basun H; Lannfelt L; Zetterberg H; Blennow K; Minthon L
    Acta Neurol Scand; 2010 Oct; 122(4):270-7. PubMed ID: 20047570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center.
    Kalkonde YV; Pinto-Patarroyo GP; Goldman T; Strutt AM; York MK; Kunik ME; Schulz PE
    Dement Geriatr Cogn Disord; 2010; 29(1):28-36. PubMed ID: 20110698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.
    Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H;
    J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer's disease.
    Goodman I; Golden G; Flitman S; Xie K; McConville M; Levy S; Zimmerman E; Lebedeva Z; Richter R; Minagar A; Averback P
    J Am Med Dir Assoc; 2007 Jan; 8(1):21-30. PubMed ID: 17210499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
    Small GW; Rabins PV; Barry PP; Buckholtz NS; DeKosky ST; Ferris SH; Finkel SI; Gwyther LP; Khachaturian ZS; Lebowitz BD; McRae TD; Morris JC; Oakley F; Schneider LS; Streim JE; Sunderland T; Teri LA; Tune LE
    JAMA; 1997 Oct 22-29; 278(16):1363-71. PubMed ID: 9343469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A descriptive analysis of ambulatory neurological care demand in Burgos Health Area.
    Martín Santidrian MA; Jiménez M; Trejo Gabriel JM; Galán
    Neurologia; 2011; 26(1):39-44. PubMed ID: 21163210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.
    Gil P; Ayuso JL; Marey JM; Antón M; Quilo CG
    Clin Drug Investig; 2008; 28(7):429-37. PubMed ID: 18544003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychogenic pathology in the neurology unit. A review of the hospital admissions over the last 10 years in a third-level service].
    de la Cruz-Cosme C; Barbieri G; Avanesi-Molina E; Romero-Acebal M
    Rev Neurol; 2011 Dec; 53(11):649-56. PubMed ID: 22086426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical stages of patients with Alzheimer disease treated in specialist clinics in Spain. The EACE study].
    Alom Poveda J; Baquero M; González-Adalid Guerreiro M
    Neurologia; 2013 Oct; 28(8):477-87. PubMed ID: 23246220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The specialist-referred patients represent 42% of the activity of an academic memory clinic].
    Croisile B; Tedesco A; Gavant S; Minssieux-Catrix G; Mollion H
    Presse Med; 2012 Jul; 41(7-8):e391-6. PubMed ID: 22336483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.